LLOYD RONALD K. 4

4 · AZIYO BIOLOGICS, INC. · Filed Mar 10, 2022

Form 4

Period: 2022-03-08

DirectorPresident and CEO

Transactions

Exercise/Conversion
Class A Common Stock
2022-03-08+4,072→ 31,775 total
Award
Stock Option (Right to Buy)
2022-03-08+138,770→ 138,770 total
Exercise: $5.08Exp: 2032-03-08→ Class A Common Stock (138,770 underlying)
Award
Restricted Stock Units
2022-03-08+37,788→ 37,788 total
→ Class A Common Stock (37,788 underlying)
Exercise/Conversion
Restricted Stock Units
2022-03-08−4,072→ 12,216 total
→ Class A Common Stock (4,072 underlying)
Award
Restricted Stock Units
2022-03-08+39,894→ 39,894 total
→ Class A Common Stock (39,894 underlying)

Footnotes (7)

[F1]Restricted stock units convert into shares of Class A Common Stock on a one-for-one basis.
[F2]Includes 4,552 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan.
[F3]The option vests as to 25% of the shares on March 8, 2023 and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2026.
[F4]Each restricted stock unit represents a contingent right to receive one share of Issuer Class A Common Stock.
[F5]The restricted stock units vest if the Issuer's Class A Common Stock achieves a price per share equal to or greater than $10.00 for any period of thirty (30) consecutive trading days prior to March 8, 2024.
[F6]On March 8, 2021, the Reporting Person was granted 16,288 restricted stock units, vesting in four substantially equal annual installments beginning on March 8, 2022.
[F7]The restricted stock units vest on September 8, 2022, subject to the Reporting Person's continuous employment with the Issuer through such vesting date.

Documents

1 file